Cyclica Announces Agreement with Merck KGaA, Darmstadt, Germany
Cyclica announced that it has entered into a licensing agreement with Merck KGaA, Darmstadt, Germany for the use of Ligand Express®, a cloud-based in silico proteome screening platform.
Previous
Previous
Exact Imaging Wins European Venture Contest Final Award
Next
Next